# SEAGEN INC. – FDA Inspection, May 1, 2017

Source: https://www.keypedia.com/records/fda_inspections/seagen-inc/ac55515f-4f67-4756-8f43-566d0f1b6cd8
Source feed: FDA_Inspections

> FDA inspection 1011478 of SEAGEN INC., May 01, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 600. Form 483 issued. 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1011478
- Company Name: SEAGEN INC.
- Inspection Date: 2017-05-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1272265 - 2025-05-13](https://www.keypedia.com/records/fda_inspections/seagen-inc/33d5bc76-b106-486b-aa5a-2ab3314b6690)
- FDA Inspection 1253880 - 2024-11-01
- FDA Inspection 1236983 - 2024-05-02
- FDA Inspection 1119141 - 2020-01-24
- FDA Inspection 1107250 - 2019-10-04

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/anita-narula/fbebf5a2-e25c-4e98-9c22-433d9102380c)

Company: https://www.keypedia.com/companies/seagen-inc/07c5dcb3-661e-4212-adfc-a00316850e38

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
